Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, explores whether cytoreductive therapies should be prescribed for low-risk patients with polycythemia vera (PV) in addition to standard phlebotomy. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
